-inc-logo.png){kind=logo}
Shares of Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Rating) shot up 1.7% on Friday . The company traded as high as $2.97 and last traded at $2.93. 130,966 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 3,376,665 shares. The stock had previously closed at $2.88.
Mind Medicine (MindMed) Stock Up 1.7 %
The business has a fifty day moving average price of $3.39 and a two-hundred day moving average price of $3.19.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Read More
- Get a free copy of the StockNews.com research report on Mind Medicine (MindMed) (MMEDF)
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
- FedEx Takes Flight; Analysts See More Gains Ahead
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
